Image-Guided Biopsy Market is estimated to Hit US$ 4.1 Billion by 2032 | Major Companies - Siemens Healthcare GmbH, GE Healthcare, Medtronic, Olympus Corporation

DataM Intelligence has unveiled its latest report on the "Image-Guided Biopsy Market Size 2026" delivering powerful insights into key trends, future growth opportunities, and evolving market challenges. Designed to empower smarter decision-making, the report equips businesses with the strategic intelligence needed to stay ahead in a competitive landscape. By blending robust qualitative analysis with data-driven quantitative research, DataM Intelligence offers a well-rounded perspective that helps organizations decode complex market dynamics, unlock new avenues for growth, and seize emerging opportunities in an ever-evolving global market.

Unlock Strategic Partnerships in the Growing Image-Guided Biopsy Market-Connect with Key Industry Leaders Today: https://www.datamintelligence.com/partner-identification-enquiry/image-guided-biopsy-market?sz

The Image-Guided Biopsy Market size reached US$ 2.5 billion in 2025 and is estimated to reach US$ 4.1 billion by 2032, growing at a CAGR of 5.5% during the forecast period (2025-2032).

The Image-Guided Biopsy Market refers to the global industry focused on minimally invasive diagnostic procedures that use imaging technologies such as ultrasound, CT, MRI, or fluoroscopy to precisely locate and sample suspicious tissues or lesions. These procedures improve accuracy, reduce complications, and enhance early disease detection, especially in cancer diagnosis. The market includes biopsy devices, imaging systems, software, and related services used in hospitals, diagnostic centers, and ambulatory surgical settings across various clinical applications and patient populations worldwide in modern healthcare.

Download Free Sample Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/image-guided-biopsy-market?sz

Recent Industry Developments: United States

✅ March 2026: Expansion of AI‐integrated biopsy navigation in interventional radiology
Several U.S. hospitals and outpatient centers began pilot deployments of AI‐assisted image‐guided biopsy navigation platforms that fuse CT, MRI, and ultrasound images with real‐time tracking. These systems are being rolled out under new reimbursement pathways that support advanced image‐guided procedures, particularly for lung, prostate, and liver lesions, with an emphasis on reducing repeat biopsies and complications.

✅ February 2026: Launch of MRI‐compatible vacuum‐assisted breast biopsy platform
A leading U.S. imaging‐and‐biopsy vendor introduced an MRI‐compatible vacuum‐assisted breast biopsy system designed for use directly inside MRI suites. The platform aims to streamline lesion localization, reduce procedural time, and improve patient comfort by enabling real‐time image‐guided sampling without moving the patient between MRI and biopsy rooms.

✅ January 2026: FDA 510(k) clearance for advanced breast biopsy system
A major U.S. medical‐device firm received FDA 510(k) clearance for a new image‐guided breast biopsy and tissue‐removal system, positioned as a minimally invasive solution that enhances targeting accuracy and workflow in mammography and ultrasound‐guided procedures. This cleared system is being integrated into outpatient breast‐care centers and radiology suites to expand portfolio offerings in vacuum‐assisted and image‐guided breast biopsies.

Recent Industry Developments: Japan

✅ March 2026: Integration of AI‐assisted navigation in ultrasound‐guided procedures
Japanese medical‐device manufacturers and imaging centers accelerated the integration of AI‐assisted navigation software into ultrasound‐guided biopsy workflows, particularly for liver, thyroid, and breast lesions. These systems use real‐time image analysis and automated lesion tracking to support less‐experienced operators and standardize biopsy accuracy across facilities, especially in tier‐2 cities with expanding imaging infrastructure.

✅ February 2026: Adoption of next‐generation disposable biopsy instruments with embedded sensors
Next‐generation disposable biopsy instruments featuring real‐time position and force‐sensing capability gained traction in Japanese hospitals and outpatient imaging centers. These devices are marketed to improve procedural precision, reduce operator dependency, and align with Japan's focus on patient safety and high‐quality minimally invasive diagnostics.

✅ January 2026: Increased insurance coverage for image‐guided core‐needle biopsies
Japan expanded its national health‐insurance coverage for image‐guided core‐needle biopsy techniques, making minimally invasive, imaging‐guided sampling more accessible in specialized oncology and radiology centers. This change is encouraging hospitals to adopt standardized ultrasound‐ and CT‐guided core‐needle protocols to replace more invasive open biopsies.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/image-guided-biopsy-market?sz

List of the Key Players in the Image-Guided Biopsy Market:

Koninklijke Philips N.V
Siemens Healthcare GmbH
GE Healthcare
Brainlab
Medtronic
Olympus Corporation
Stryker
Hologic Inc.

How Does Market Research Work in the Image-Guided Biopsy Market?

Market research for the Image-Guided Biopsy Market involves systematic data collection and analysis to understand industry trends, customer behavior, and competitive dynamics. It includes primary research such as surveys and interviews, and secondary research from reports, databases, and publications. Analysts evaluate market size, growth drivers, challenges, and opportunities using qualitative and quantitative methods. Insights are validated through expert opinions and forecasting models, enabling businesses to make strategic decisions, identify target segments, and gain a competitive advantage in a rapidly evolving market.

Latest Mergers and Acquisitions of Image-Guided Biopsy Market:

✅ March-April 2026: Diagnostic Imaging & Biopsy Technology Consolidation Deals
➠ During early Q1-Q2 2026, continued consolidation occurred across the image-guided surgery and robotic-assisted procedures market, which overlaps strongly with image-guided biopsy systems (especially prostate, breast, and lung biopsy robotics).
➠ Companies expanded portfolios through acquisitions of:
Robotic-assisted biopsy navigation systems
Imaging software for lesion detection
Ultrasound-guided biopsy assistance platforms
➠ This consolidation trend is part of broader integration across interventional radiology + diagnostic biopsy ecosystems.
➠ Relevance: Directly impacts CT/MRI/ultrasound-guided biopsy workflows and robotic biopsy platforms.

✅ February 2026: Pipeline-Focused MedTech Acquisition Activity
➠ In February 2026, healthcare deal activity showed a shift toward pipeline-driven acquisitions in diagnostic and oncology-focused device technologies, including companies developing minimally invasive tissue sampling and image-guided procedural tools.
➠ Large strategic buyers prioritized assets in precision oncology diagnostics and biopsy guidance innovation platforms, reflecting growing demand for early cancer detection solutions.
➠ Relevance: Includes early-stage acquisition interest in biopsy navigation systems, lesion localization tools, and AI-assisted imaging platforms.

✅ January 2026: Strategic Acquisition Expansion in Image-Guided Interventional Portfolio
➠ A major medtech consolidation activity in early 2026 involved expansion of image-guided and minimally invasive diagnostic portfolios, including biopsy guidance systems and robotic-assisted biopsy technologies. Large medtech companies focused on strengthening oncology diagnostics and precision biopsy capabilities through targeted acquisitions of smaller imaging-navigation technology firms.
➠ Relevance: Strengthens CT/MRI/ultrasound-guided biopsy workflow integration and AI-based targeting tools in biopsy procedures.

Segments Covered in the Image-Guided Biopsy Market 2026:

By Technology: X- Ray, Ultrasound, Mammography, CT, MRI, Others.

By Process: Fine Needle, Core Needle, Vacuum- Assisted Biopsy, Others.

By Indication: Cancer, Liver Disease, Kidney Disease, Infectious Diseases, Others.

By End user: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers, Research Institutes, Others.

Regional Analysis of the Image-Guided Biopsy Market:

⇥ North America: Leads the market due to advanced infrastructure, strong R&D investments, and early adoption of new technologies.

⇥ Europe: Shows steady growth supported by strict regulations and increasing focus on sustainability initiatives.

⇥ Asia-Pacific: Fastest-growing region driven by rapid industrialization, urbanization, and rising consumer demand in emerging economies.

⇥ Latin America: Experiences moderate growth with expansion in industrial and commercial sectors.

⇥ Middle East & Africa: Gradual market growth supported by increasing investments and improving economic conditions.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=image-guided-biopsy-market

Key Benefits of the Report:

⏩ Comprehensive Market Insights: Gain a deep understanding of market size, trends, and structure.

⏩ Accurate Forecasting: Access reliable future projections to support long-term planning.

⏩ Competitive Analysis: Identify key players, strategies, and positioning in the market.

⏩ Data-Driven Decisions: Make informed business choices backed by verified data.

⏩ Opportunity Identification: Discover emerging trends and untapped growth areas.

⏩ Risk Mitigation: Reduce uncertainties with thorough market evaluation.

⏩ Customer Insights: Understand consumer behavior, preferences, and buying patterns.

⏩ Strategic Planning Support: Align business strategies with market realities.

⏩ Time & Cost Efficiency: Save resources by leveraging ready-to-use research.

⏩ Customization & Expert Validation: Benefit from tailored insights and industry expert analysis.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Image-Guided Biopsy Market in 2025?
◆ What is the projected growth rate of the Image-Guided Biopsy Market through 2033?
◆ Who are the key players in the Image-Guided Biopsy Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Fabian
Email: fabian@datamintelligence.com
Phone USA: +1 877-441-4866
Phone UK: +44 161-870-5507
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.